Veterinary Medicine Information website

EURICAN DAP-LR, liofilizatas ir suspensija injekcinei suspensijai

Not authorised
  • Canine parvovirus, strain CAG2, Live
  • Canine adenovirus 2, strain DK13, Live
  • Canine distemper virus, strain BA5, Live
Download as PDF

Product identification

Medicine name:
EURICAN DAP-LR, liofilizatas ir suspensija injekcinei suspensijai
Active substance:
  • Canine parvovirus, strain CAG2, Live
  • Canine adenovirus 2, strain DK13, Live
  • Canine distemper virus, strain BA5, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parvovirus, strain CAG2, Live
    79432.80
    50% cell culture infectious dose
    /
    1.00
    Dose
  • Canine adenovirus 2, strain DK13, Live
    316.23
    50% cell culture infectious dose
    /
    1.00
    Dose
  • Canine distemper virus, strain BA5, Live
    10000.00
    50% cell culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI05
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
  • Surrendered
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/95/0252/001-002
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 7/12/2022
Download